Page last updated: 2024-08-18

pyrroles and Foot Dermatoses

pyrroles has been researched along with Foot Dermatoses in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's8 (72.73)29.6817
2010's3 (27.27)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gerami, P; Guitart, J; Lacouture, ME; Reilly, LM1
Alexandrescu, DT; Anderson, RT; Atkins, MB; Dutcher, JP; Garbe, C; Guitart, J; Hauschild, A; Kong, HH; Lacouture, ME; Puzanov, I; Robert, C; Wood, L; Wu, S1
Boone, SL; Jameson, G; Lacouture, ME; Von Hoff, D1
Feyerabend, S; Schilling, D; Stenzl, A; Wicke, C1
Behnam, SE; Fife, DJ; Linden, KG; Wu, JJ1
Chang, SE; Choi, JH; Kang, YK; Koh, JK; Lee, JL; Lee, MW; Lee, WJ; Moon, KC1
Lipworth, AD; Robert, C; Zhu, AX1
Bednaríková, D; Kocák, I1
Anderson, L; Bhattacharya, S; Bose, N; Fraser, E; Graham, K; Lumsden, G; McClue, L; Robertson, L; Tho, LM; Yosef, H1
Gross, B; Hättenschwiler, A; Schulthess, G; Widmer, Ch1
Berg, BC; Chow, S; Suwattee, P; Warshaw, EM1

Reviews

3 review(s) available for pyrroles and Foot Dermatoses

ArticleYear
Evolving strategies for the management of hand-foot skin reaction associated with the multitargeted kinase inhibitors sorafenib and sunitinib.
    The oncologist, 2008, Volume: 13, Issue:9

    Topics: Benzenesulfonates; Foot Dermatoses; Hand Dermatoses; Humans; Indoles; Neoplasms; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyridines; Pyrroles; Quality of Life; Receptors, Vascular Endothelial Growth Factor; Sorafenib; Sunitinib

2008
Hand-foot syndrome (hand-foot skin reaction, palmar-plantar erythrodysesthesia): focus on sorafenib and sunitinib.
    Oncology, 2009, Volume: 77, Issue:5

    Topics: Antineoplastic Agents; Benzenesulfonates; Drug Eruptions; Erythema; Foot Dermatoses; Hand Dermatoses; Humans; Indoles; Niacinamide; Paresthesia; Phenylurea Compounds; Prognosis; Pyridines; Pyrroles; Risk Factors; Sorafenib; Sunitinib; Syndrome

2009
[Hand-foot syndrome after administration of tyrosinkinase inhibitors].
    Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti, 2010, Volume: 23, Issue:5

    Topics: Antineoplastic Agents; Benzenesulfonates; Drug Eruptions; Foot Dermatoses; Hand Dermatoses; Humans; Indoles; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyridines; Pyrroles; Sorafenib; Sunitinib; Syndrome

2010

Other Studies

8 other study(ies) available for pyrroles and Foot Dermatoses

ArticleYear
Hand foot skin reaction in cancer patients treated with the multikinase inhibitors sorafenib and sunitinib.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2008, Volume: 19, Issue:11

    Topics: Administration, Topical; Aged; Aged, 80 and over; Antineoplastic Agents; Benzenesulfonates; Carcinoma, Hepatocellular; Carcinoma, Renal Cell; Female; Fluorouracil; Foot Dermatoses; Hand Dermatoses; Humans; Indoles; Kidney Neoplasms; Liver Neoplasms; Male; Middle Aged; Niacinamide; Nicotinic Acids; Phenylurea Compounds; Protein Kinase Inhibitors; Pyridines; Pyrroles; Sorafenib; Sunitinib; Urea

2008
Blackberry-induced hand-foot skin reaction to sunitinib.
    Investigational new drugs, 2009, Volume: 27, Issue:4

    Topics: Antineoplastic Agents; Cell Phone; Colorectal Neoplasms; Drug Eruptions; Female; Foot Dermatoses; Hand Dermatoses; Humans; Indoles; Middle Aged; Pyrroles; Sunitinib

2009
Toxic dermatolysis, tissue necrosis and impaired wound healing due to sunitinib treatment leading to forefoot amputation.
    Urologia internationalis, 2009, Volume: 82, Issue:2

    Topics: Aged; Amputation, Surgical; Angiogenesis Inhibitors; Anti-Bacterial Agents; Carcinoma, Renal Cell; Cutis Laxa; Debridement; Foot Dermatoses; Forefoot, Human; Humans; Indoles; Kidney Neoplasms; Male; Nephrectomy; Pyrroles; Stevens-Johnson Syndrome; Sunitinib; Treatment Outcome; Wound Healing

2009
Sunitinib-induced hand-foot syndrome: a new, distinct form.
    Clinical and experimental dermatology, 2010, Volume: 35, Issue:2

    Topics: Aged; Antineoplastic Agents; Drug Eruptions; Foot Dermatoses; Hand Dermatoses; Humans; Indoles; Male; Pyrroles; Sunitinib; Syndrome

2010
Cutaneous adverse effects in patients treated with the multitargeted kinase inhibitors sorafenib and sunitinib.
    The British journal of dermatology, 2009, Volume: 161, Issue:5

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Alopecia; Antineoplastic Agents; Benzenesulfonates; Carcinoma, Hepatocellular; Carcinoma, Renal Cell; Drug Eruptions; Female; Foot Dermatoses; Gastrointestinal Stromal Tumors; Hand Dermatoses; Humans; Indoles; Kidney Neoplasms; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyridines; Pyrroles; Retrospective Studies; Skin Diseases; Sorafenib; Stomatitis; Sunitinib; Young Adult

2009
Trastuzumab-related palmar plantar erythrodysaesthesia.
    Clinical oncology (Royal College of Radiologists (Great Britain)), 2012, Volume: 24, Issue:1

    Topics: Aged; Amlodipine; Antibodies, Monoclonal, Humanized; Anticholesteremic Agents; Antihypertensive Agents; Antineoplastic Agents; Atorvastatin; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Foot Dermatoses; Hand Dermatoses; Heptanoic Acids; Humans; Hypercholesterolemia; Hypertension; Pyrroles; Trastuzumab

2012
["Gout tophi" and heart disease in the family].
    Praxis, 2003, Nov-05, Volume: 92, Issue:45

    Topics: Adult; Arcus Senilis; Atorvastatin; Cholesterol; Cholesterol, HDL; Diagnosis, Differential; Female; Follow-Up Studies; Foot Dermatoses; Hand Dermatoses; Heart Diseases; Heptanoic Acids; Humans; Hyperlipoproteinemia Type II; Hypolipidemic Agents; Male; Middle Aged; Pyrroles; Time Factors; Xanthomatosis

2003
Sunitinib: a cause of bullous palmoplantar erythrodysesthesia, periungual erythema, and mucositis.
    Archives of dermatology, 2008, Volume: 144, Issue:1

    Topics: Antineoplastic Agents; Carcinoid Tumor; Drug Eruptions; Erythema; Follow-Up Studies; Foot Dermatoses; Hand Dermatoses; Humans; Immunosuppressive Agents; Indoles; Male; Middle Aged; Mouth Mucosa; Mucositis; Pyrroles; Risk Assessment; Skin Diseases, Vesiculobullous; Sunitinib; Treatment Outcome

2008